TopFunds

Waters corporation

NYSE: WAT

Stock price

436.95 USD

(+0%) TODAY

Medical - Diagnostics & Research
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
5.7
6.4
0.3
7.7
8.7
8.4
11.2
11.7
10.8
10.7
10.8
6.7%
02Free cash flow per share
5.5
6.6
7.5
6.1
7
9.9
9.3
7.1
7.5
10.4
9
5.1%
03Dividends per share
-
-
-
-
-
-
-
-
-
-
-
-
04Dividends payout, %
-
-
-
-
-
-
-
-
-
-
-
-
PROFIT AND LOSS STATEMENT
05Revenue
2,042
2,167
2,309
2,420
2,407
2,365
2,786
2,972
2,956
2,958
3,165
4.5%
06% Change
-
-
-
-
-
-
-
-
-
-
-
4.5%
07Cost of revenue
(842.7)
(891.5)
(947.1)
(992.6)
(1,011)
(1,007)
(1,157)
(1,248)
(1,195)
(1,200)
(1,337)
4.7%
08Gross profit
1,200
1,276
1,362
1,427
1,396
1,359
1,629
1,724
1,761
1,758
1,829
4.3%
09% Margin
58.7%
58.9%
59%
59%
58%
57.4%
58.5%
58%
59.6%
59.4%
57.8%
58.6% A
10Operating expenses
(632.2)
(650.9)
(699.8)
(687.6)
(687.4)
(713.2)
(807.6)
(850.4)
(943.5)
(931.8)
(935.4)
4%
11% of Revenue
(31)%
(30)%
(30.3)%
(28.4)%
(28.6)%
(30.2)%
(29)%
(28.6)%
(31.9)%
(31.5)%
(29.6)%
(29.9)% A
12Operating Income
567.5
625
662.2
739.8
708.5
645.5
821.7
873.4
817.7
826.4
893.2
4.6%
13Income tax expense
(72.9)
(78.6)
(620.8)
(88.4)
(86)
(89.3)
(113.3)
(130.1)
(94)
(117)
(112.2)
4.4%
14Net Income
469.1
521.5
20.3
593.8
592.2
521.6
692.8
707.8
642.2
637.8
642.6
3.2%
15% Margin
23%
24.1%
0.9%
24.5%
24.6%
22.1%
24.9%
23.8%
21.7%
21.6%
20.3%
21% A
16Shares Outstanding
83.1
81.4
80.6
77.6
68.2
62.4
62
60.3
59.3
59.6
59.7
(3.3)%
17EPS Basic
5.7
6.5
0.3
7.7
8.8
8.4
11.3
11.8
10.9
10.8
10.8
6.6%
18EPS Diluted
5.7
6.4
0.3
7.7
8.7
8.4
11.2
11.7
10.8
10.7
10.8
6.7%
19EBITDA
668.1
741.5
803.9
839.2
832.2
785.3
982.8
1,017
1,001
1,036
1,012
4.2%
% Margin
32.7%
34.2%
34.8%
34.7%
34.6%
33.2%
35.3%
34.2%
33.9%
35%
32%
34.1% A
20Net Interest Income (expense)
(25.5)
(24.2)
(20.8)
(9.8)
(26.6)
(32.8)
(32.7)
(37.8)
(82.2)
(72.3)
(62.2)
9.3%
21Net Debt / EBITDA
1.8
1.8
1.7
0.4
1.7
1.3
1.1
1.2
2
1.3
0.9
1.4 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
487.7
505.6
642.3
796.3
335.7
436.7
501.2
480.5
395.1
324.4
587.8
1.9%
23Short-term investments
1,912
2,307
2,751
938.9
1.4
6.5
68.1
0.9
0.9
0.9
-
-
24Accounts receivable
468.3
489.3
533.8
568.3
587.7
573.3
612.6
722.9
702.2
733.4
828.8
5.9%
25Other current assets
82.5
70.4
72.3
68.1
67.1
80.3
90.9
103.9
138.5
133.1
158.6
6.8%
26Inventory
263.4
262.7
270.3
291.6
320.6
304.3
356.1
455.7
516.2
477.3
572.4
8.1%
27Total Current Assets
3,214
3,635
4,270
2,663
1,313
1,401
1,629
1,764
1,753
1,669
2,148
(4)%
Non-Current Assets
28Net property, plant & equipment
333.4
337.1
349.3
343.1
510.7
587.3
632.6
668.7
723.7
725.4
722.8
8.1%
29Long-term investments
-
-
-
-
-
-
-
-
-
-
0.3
-
30Other non-current assets
721.8
689.5
704.9
721.2
733.9
851.6
833.3
848.8
2,150
2,159
2,206
11.8%
31Total Non-Current Assets
1,055
1,027
1,054
1,064
1,245
1,439
1,466
1,518
2,874
2,885
2,929
10.8%
Total Assets
4,261
4,662
5,340
3,727
2,557
2,840
3,095
3,282
4,627
4,554
5,077
1.8%
LIABILITIES
Current Liabilities
32Accounts payable
70.6
67.7
64.5
68.2
49
72.2
96.8
93.3
84.7
99.9
103.8
3.9%
33Short-term debt
175.3
125.3
100.3
0.2
127.5
177.8
27.9
76.4
77.8
25.5
491.1
10.9%
34Other current liabilities
318.2
327.3
441.3
380.6
414.8
555
555.8
616
627.1
664.3
644.6
7.3%
35Total Current Liabilities
564.1
520.3
606.2
448.9
591.3
805
680.5
785.7
789.6
789.8
1,240
8.2%
Non-Current Liabilities
36Long-term debt
1,493
1,702
1,898
1,148
1,648
1,275
1,574
1,587
2,364
1,677
1,000
(3.9)%
37Other non-current liabilities
152.7
137.8
586.9
563.1
534.3
528.1
473.4
404.2
322.5
258.7
275.8
6.1%
38Total Non-Current Liabilities
1,646
1,840
2,484
1,711
2,182
1,803
2,047
1,991
2,687
1,936
1,276
(2.5)%
39Total Liabilities
2,202
2,360
3,106
2,160
2,773
2,608
2,727
2,777
3,477
2,725
2,515
1.3%
SHAREHOLDERS` EQUITY
40Common stock
1.6
1.6
1.6
1.6
1.6
1.6
1.6
1.6
1.6
1.6
1.6
0.3%
41Retained earnings / (deficit)
4,864
5,385
5,405
5,995
6,587
7,108
7,801
8,509
9,151
9,789
10,431
7.9%
42Accumulated other comprehensive income / (loss)
(146.7)
(216.3)
(110.1)
(118)
(119.5)
(117.9)
(111.9)
(141.6)
(134.1)
(155.3)
(125.5)
(1.6)%
43Noncontrolling interests
-
-
-
-
-
-
-
-
-
-
-
-
44Total shareholders' equity
2,059
2,302
2,234
1,567
(216.3)
232.1
367.6
504.5
1,150
1,829
2,561
2.2%
45Total Liabilities and shareholders' Equity
4,261
4,662
5,340
3,727
2,557
2,840
3,095
3,282
4,627
4,554
5,077
1.8%
46Total Debt
1,668
1,827
1,998
1,148
1,775
1,453
1,601
1,663
2,442
1,702
1,491
(1.1)%
47Net Debt
1,181
1,322
1,356
352.1
1,440
1,016
1,100
1,183
2,047
1,378
903.3
(2.6)%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
469.1
521.5
20.3
593.8
592.2
521.6
692.8
707.8
642.2
637.8
642.6
3.2%
49Depreciation & amortization
90
96.4
106
108.4
105.3
125.4
131.7
130.4
165.9
191.8
206.2
8.7%
50Share-based compensation expense
33.4
41
39.4
37.5
38.6
36.9
29.9
42.6
36.9
44.7
54.1
5%
51Changes in working capital and other assets
(32.1)
(29.9)
531.9
(135.3)
(93)
106.7
(107.2)
(269.1)
(242.2)
(112.2)
(250.4)
22.8%
52Net cash flows from operating activities
560.3
629.1
697.6
604.4
643.1
790.5
747.3
611.7
602.8
762.1
652.6
1.5%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(103)
(95)
(90.5)
(127.6)
(163.8)
(172.4)
(168.3)
(183.5)
(160.6)
(142.5)
(112.7)
0.9%
54Purchases of investments / marketable securities
(2,010)
(2,396)
(445.3)
(7.6)
(8.8)
(32)
(63.4)
(11.4)
(1.8)
(3.7)
(7.3)
(43)%
55Proceeds from maturities of marketable securities
1,732
2,005
2,522
1,819
941.5
20.9
218.1
86.9
2.5
3.7
-
-
56Other investing activities
(18.3)
(1.6)
(2,522)
-
-
(80.5)
(218.1)
-
(1,282)
(1.5)
(32.2)
5.8%
57Net cash flows from investing activities
(399.7)
(487.9)
(535.8)
1,683
768.8
(264.1)
(231.6)
(108)
(1,442)
(144)
(152.3)
(9.2)%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
(334.7)
(325.8)
(332.5)
(1,315)
(2,469)
(196.4)
(648.9)
(626.1)
(70.3)
(13.5)
6.1
-
59Dividends paid, net
-
-
-
-
-
-
-
-
-
-
-
-
60Debt issuance (repayments), net
205.1
160
170
(850.2)
535.2
(325.4)
160
60
780
(730)
(243.3)
-
61Other financing activities
60
63.9
98.7
45.7
61.4
81.3
50.7
56.4
45.2
46.9
-
-
62Net cash flows from financing activities
(69.6)
(101.9)
(63.9)
(2,120)
(1,873)
(440.5)
(438.3)
(509.6)
755
(696.7)
(237.2)
13.1%
63Increase (decrease) in cash and cash equivalents
65.5
18
136.7
154
(460.6)
101
64.5
(20.7)
(85.5)
(70.7)
262.5
14.9%
64Cash and equivalents, ending balance
487.7
505.6
642.3
796.3
335.7
436.7
501.2
480.5
395.1
324.4
587.8
1.9%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
457.3
534.1
607.2
476.9
479.3
618.1
579
428.2
442.2
619.6
539.8
1.7%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019201820172016

Waters corporation (WAT) financial statements and performance

Explore Waters corporation (WAT) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.